Staff Directory

Photo of Judy Blumstock
Executive Director, Corporate Development
Work Phone: 647-260-7863

Biographical Info

Judith provides financial strategy and in-depth portfolio reporting for MaRS Innovation and its technologies and companies under management. She also takes an active role in fundraising and investor relations, and leads a variety of special projects.

Prior to joining MaRS Innovation, Judith was a principal with Genesys Capital Partners, one of the largest Canadian-based venture-capital firms focused on the life sciences industry. She is also a past director of Insception, Millenium Biologix Corp., Plexagen Diagnostics, and Zelos Therapeutics Inc. Previously, Judith was a partner with Royal Bank Capital Partners Life Sciences Fund and, prior to that, director of Bio/pharmaceutical Research at Drug Royalty Corporation.

Judith received her M.B.A. in finance from Columbia Business School and her B.Sc. in Biology from the University of Toronto.

Return to top.
Photo of Kevin Canning
Director, Technology & Venture Development

Biographical Info

As Director, Technology & Venture Development for the life sciences, Kevin develops strategies to bring medicines invented in the local scientific community to patients.  He does this by assessing the unmet medical need, the standard of care, and the patient journey in relation to the business potential of an opportunity. He performs technical and market due diligence and evaluates the competitive positioning and advantages of new technologies to support and expand MaRS Innovation’s portfolio. He develops business, technical, strategic and financing plans to bring new start-up ventures to fruition. He also actively markets technologies to support licensing, co-development and other commercialization transactions.

Kevin has over fifteen years of leadership and people-management experience in roles of increasing responsibility in the pharmaceutical industry.  He has worked in, and led teams in, basic research and genetics, research alliances/scouting, venture capital, clinical research, statistics, epidemiology, data management, medical development, commercial assessment, medical affairs, outsourcing and contracts, strategy and operations.

Prior to joining MaRS Innovation Kevin spent more than three years at GSK China R&D in Shanghai as Director, Strategy and Operations. In addition to leading teams and programs in China, Kevin was secretary to the Portfolio Board of GSK China, supporting the Board’s optimal decision-making in choosing which assets to develop for China and how to develop them.

Kevin holds a Ph.D. and an H.B.Sc. in Physiology, both from Western University. He holds an M.B.A. from the Ivey Business School, Western University and was recognized as an Ivey Scholar in this program.

Return to top.
Photo of Jasmine Dautovich
Manager, Technology and Venture Development
Work Phone: 647-260-7897

Biographical Info

Jasmine Dautovich supports the MaRS Innovation life science portfolio through evaluation of early-stage technologies by conducting scientific, technical and intellectual property due diligence, assessing market potential and identifying potential industry partners to support new start-up ventures.

Prior to joining MaRS Innovation, Jasmine was the Manager of Operations and Clinical Development for a clinical-stage biotechnology company, ScarX Therapeutics, where she was responsible for managing all aspects of technology development through to successful completion of a Phase I clinical trial.

Jasmine holds a M.Sc. in Pharmaceutical Sciences from the University of Toronto and a B.Sc. in Molecular Biology & Genetics from McMaster University.

Return to top.
Photo of Mary Fournier-Park
IP Information Administrator
Work Phone: 647-260-7865

Biographical Info

Mary maintains MaRS Innovation’s main disclosure and Intellectual Property (IP) databases. Her role includes facilitating agreement execution, financial tracking and managing the IP portfolio.

Mary has more than a decade of experience spanning trademark and patent prosecution, including domestic and foreign jurisdiction filings, as well as general maintenance of trademark and patent applications. She also has extensive experience bridging communications between and amongst management committees, senior executives and external clients.

Most recently, Mary was the trademark and patent assistant for a large, full-service, Toronto-based law firm.

Return to top.
Photo of Phil Goldbach
Manager, Technology and Venture Development; Manager, Intellectual Property
Work Phone: 647-260-7830

Biographical Info

Phil manages intellectual property (IP) rights across all technologies within MaRS Innovation’s portfolio. He advises on various forms of IP protection, assessing patentability and managing patent application filings and prosecution decisions. Phil also manages projects in MI’s Life Sciences portfolio. He performs technical and market due diligence on new technologies to support and grow MI’s portfolio. In addition, he develops business, technical, and strategic plans and engages with industry partners in order to support new start-up ventures.

Prior to joining MaRS Innovation, Phil trained with an intellectual property boutique law firm in downtown Toronto as a member of the firm’s life sciences patent practice group, where he was exposed to a wide array of technologies including biologics, small molecules, medical devices, and information technologies. He has also acted as director of intellectual property for a biotechnology start-up company in Mississauga that specializes in developing antibody-based products for use in animal health and food safety.

Phil holds a PhD in Molecular Genetics from the University of Toronto and a JD from Osgoode Hall Law School.

Return to top.
Photo of Stacey Ivanchuk
Director, Intellectual Property
Work Phone: 647-260-7867

Biographical Info

Stacey has over 10 years experience relating to intellectual property (IP) protection, management and strategy. She oversees and provides strategic advice for all projects in MaRS Innovation’s portfolio spanning diverse technical fields, working closely with the venture development teams to evaluate technologies and develop optimal IP protection strategies. In addition to her IP role, she is responsible for strategic oversight of all technologies originating from Baycrest, a MaRS Innovation member.

Prior to MaRS Innovation, Stacey was IP manager at Topigen Pharmaceuticals Inc., a Montreal-based biotechnology company (acquired by Pharmaxis Ltd.) where she provided IP-related strategic guidance including portfolio management, budgeting and financial forecasting. She was also formerly IP consultant at Baycrest where she identified and assessed commercial opportunities arising from neurocognitive research. In her role as Scientific Advisor in the IP group of Ogilvy Renault (now Norton Rose Fulbright), she gained experience drafting and prosecuting patent applications, focusing on life sciences/biotechnology patent protection.

Stacey received her B.Sc., Honours (Biology) and M.Sc. in cancer genetics from Queen’s University and her Ph.D. in molecular biology from the University of Toronto.

Return to top.
Photo of Hassan Jaferi
Manager, UTEST
Work Phone: 647-531-4681

Biographical Info

As Manager of UTEST, Hassan works with early-stage startup companies from the University of Toronto and its affiliated hospitals. He helps guide UTEST portfolio companies in the areas of business development, marketing, intellectual property, fundraising and strategy.

Previously, Hassan was a commercialization manager at MaRS Innovation where he divided his time between projects located in Innovation York and Sunnybrook Health Sciences Centre’s Technology Transfer office, located in the Sunnybrook Research Institute. He conducted due diligence on invention disclosures, aided in patent application preparation and prosecution, executed business development for early-stage technologies and pursued public and private funding to advance early-stage research projects.

Before joining MaRS Innovation, Hassan was a commercial development analyst with PARTEQ Innovations, the technology transfer office of Queen’s University, where he managed the commercialization of early-stage technologies and helped managed a start-up company. He has also worked as a patent examiner with the Canadian Intellectual Property Office.

Hassan holds a M.Sc. in space management from the International Space University in Strasbourg, France, and a B.Sc. in computer engineering from the University of Ottawa.

Return to top.
Photo of Timothy Key
Manager, Technology & Venture Development
Work Phone: 647-260-7843

Biographical Info

Tim manages projects in MI’s Life Sciences portfolio. He performs technical and market due diligence and evaluates the competitive positioning and advantages of new technologies to support and grow MI’s portfolio. He develops business, technical, strategic and financing plans to support new start-up ventures. He also actively markets technologies to support licensing, co-development and other commercialization transactions.

Prior to joining MI, Tim worked in Vancouver for the Centre for Drug Research and Development, another Centre of Excellence for Commercialization and Research (CECR), where he worked in small molecule/biologic drug discovery R&D and business development.

Tim holds a Ph.D in Microbiology and Immunology from Dalhousie University in Halifax, NS, and a B.Sc in Biochemistry from Mount Allison University in Sackville, NB.

Return to top.
Photo of Laura McLachlan
Manager, Commercialization
Cell Phone: 647 327 4020Website:

Biographical Info

As a commercialization manager at MaRS Innovation, Laura works with scientific and clinical researchers to identify, develop and commercialize novel technologies at St Michael’s Hospital. She provides technology transfer services, including evaluation of invention disclosures, patent preparation and business development activities for early-stage technologies and inventions. This also includes securing funding from both public and private sources to advance early-stage research, developing licensing opportunities and helping to create and manage start-up companies.

Laura has ten years of technology transfer experience spanning the academic, industrial and legal field. Prior to joining MaRS Innovation, she was the Intellectual Property Associate at a UK university where she co-managed licensing and start-up creation. She also worked as a technical assistant at a large Toronto-based IP Law firm.

Laura holds a Ph.D. in Materials Science, a B.Sc. in Biology, and an LLM in Intellectual Property Law from the University of Manchester, UK.

Return to top.
Photo of Abu Nana
Accounting Specialist, New Ventures
Work Phone: 647-260-7864

Biographical Info

Abu conducts the day-to-day accounting and finance activities for several new ventures within MaRS Innovation, including Encycle Therapeutics, QD Solar, Vasomune Therapeutics, Bright Angel Therapeutics and Fibrocor Therapeutics. He manages their financial reporting and compliance with GAAP (Generally Accepted Accounting Principles).

Prior to joining MaRS Innovation, Abu was an accountant at MaRS Discovery District, where he managed cash-flow forecasting and assisted in reconciling internal company accounts. He also worked with management and co-workers to improve financial policies and procedures within the organization.

Abu holds a BComm from Ryerson University and earned his Chartered Professional Accounting (CPA) designation while working at MaRS Discovery District.

Return to top.
Photo of Parimal Nathwani
Work Phone: 647-260-7873

Biographical Info

Parimal Nathwani has over 15 years of experience in various aspects of the biotechnology industry including corporate finance, business development, transactions, intellectual property management, technology development and operations. He has been actively involved in forming and managing start-ups, preparing and executing on business plans, raising early-stage capital and in- and out-licensing activities.

Before joining MaRS Innovation, Parimal was a healthcare analyst with a boutique investment bank, where he conducted equity research on publicly-traded biotechnology companies in Canada and the U.S. He has also led commercialization activities out of BC Women’s and Children’s Hospital as part of his role at the University of British Columbia’s Industry Liaison Office, and was a research scientist at a start-up biotechnology company involved in drug discovery targeting ABC Transporters.

Parimal received his MBA from Simon Fraser University and his M.Sc. from the University of British Columbia.  He currently sits on the boards of TRIUMF Innovations, Zucara Therapeutics, Cohesys Inc. and Vasomune Therapeutics, and is an observer on the board of Encycle Therapeutics.

Return to top.
Photo of Samir Sahoo
Manager, Technology and Venture Development
Work Phone: 647-260-7831

Biographical Info

Samir has been working in the Healthcare/Medical Device space for over 7 years and has worked with a number of start-up companies in Microfluidics, Diagnostics and Healthcare IT. He has been responsible for in-depth due diligence with Health businesses and startups.  More recently he has been working in the orthopaedics and musculoskeletal space in US and Canada, managing Spinal Implants, Orthobiologics products and Surgical Power Tool portfolios at Zimmer. He was responsible for managing the overall P/L for his portfolios and making end-to-end business decisions which included: new product launches, customer relationship management, achieving revenue and profitability targets, sales training, surgeon education, capital investment and inventory management.

Over the last 5 years at Zimmer, Samir managed a number of high-visibility projects including a global portfolio rationalization project and a number of new product launches.

Samir has a Bachelor’s degree in Engineering and an MBA from Purdue University, Indiana, U.S. During the MBA program, Samir held several leadership positions, one of which was the President of Net Impact Purdue Chapter. In this role, he created sustainable hybrid business opportunities and developed experiential learning projects in healthcare and commercialization of a number of healthcare and green energy technologies.

Return to top.
Photo of Susanne Staer
Manager, Corporate Affairs
Work Phone: 647-260-7869

Biographical Info

Susanne is the Corporate Secretary for MaRS Innovation and as such is in charge of the integrity of the organization’s governance framework, including compliance with various governing and funding requirements; efficient administration of the Board of Directors and its various governing and advisory committees; and management of the process related to the annual general meetings and accurate record keeping of Board decisions and organizational history.

In addition, Susanne delivers administrative expertise to the executive office, and oversees marketing, external communications, social media and website development. She maintains office efficiency by establishing procedures and standards, and is the point-person for all aspects of the administration of MaRS Innovation.

Prior to joining MaRS Innovation, Susanne worked closely with to two senior partners in a nation-wide law firm, in the areas of mergers and acquisitions, corporate finance and securities, and general corporate matters. Susanne also trained new administrative staff and was instrumental in setting up various internal intranet functions as they pertained to training and staff administration.

Susanne has an international administrative background through her work in the diplomatic corps under the Ministry of Foreign Affairs of Denmark, through which she was posted to the Royal Danish Embassies in Russia and Ghana.

Return to top.
Photo of Jackie Terry
Executive Assistant to the Vice President
Work Phone: 647-260-7870

Biographical Info

In addition to her responsibilities as EA to the Vice President, Jackie provides administrative support to the boards of several of MaRS Innovation’s startup companies.  She also assists with the daily administration of the LAB150 funding initiative for new drug discovery, and is the liaison between MaRS Innovation and our partner, Evotec AG, as well as the main contact for the Technology Transfer Offices and researchers at our Member institutions who wish to apply to the LAB150 program.

Prior to joining MI, Jackie collaborated on and managed projects in the polymer characterization department of an organization that specialized in contract and service-based research, development and testing. Her specialties were innovative techniques for preparing and analyzing materials using various disciplines of microscopy, particularly scanning electron microscopy, mainly in the fields of materials characterization and failure analysis.

Jackie received her B. Sc. in Chemistry from McMaster University in Hamilton, Ontario.

Return to top.